{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:15:40Z","timestamp":1787944540554,"version":"build-2784847793"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004046","name":"Karen Elise Jensen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003554","name":"Lundbeck Foundation","doi-asserted-by":"publisher","award":["R307-2018-3672"],"award-info":[{"award-number":["R307-2018-3672"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijcha.2025.101832","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:35:04Z","timestamp":1762313704000},"page":"101832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["High-sensitivity C-reactive protein is associated with altered cardiac structure and function in psoriasis: The PSOCADIA study"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3506-6862","authenticated-orcid":false,"given":"Maria","family":"Dons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Sengel\u00f8v","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristoffer Grundtvig","family":"Skaarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niklas Dyrby","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mats C.H.","family":"Lassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"B\u00f8gh-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie I.H.","family":"Borchsenius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip Soeskov","family":"Davidovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino E.","family":"Landler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoffer V.","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Riis","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany N.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus","family":"Zachariae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor","family":"Biering-S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2025.101832_b0005","doi-asserted-by":"crossref","unstructured":"Snekvik I, Nilsen T i. l., Romundstad P r., Saunes M. Psoriasis and cardiovascular disease risk factors: the HUNT Study, Norway. J Eur Acad Dermatol Venereol. 2018;32(5):776-782. doi:10.1111\/jdv.14835.","DOI":"10.1111\/jdv.14835"},{"key":"10.1016\/j.ijcha.2025.101832_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2024.152416","article-title":"Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: a population-based cohort study","volume":"65","author":"Meng","year":"2024","journal-title":"Semin. Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.ijcha.2025.101832_b0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41569-019-0315-x","article-title":"Reappraising the role of inflammation in heart failure","volume":"17","author":"Adamo","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101832_b0020","doi-asserted-by":"crossref","first-page":"948","DOI":"10.3390\/biom14080948","article-title":"Inflammation: is it a healer, confounder, or a promoter of cardiometabolic risks?","volume":"14","author":"Tate","year":"2024","journal-title":"Biomolecules"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101832_b0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/ard-2022-223302","article-title":"Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritis","volume":"82","author":"Solomon","year":"2023","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101832_b0030","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101832_b0035","doi-asserted-by":"crossref","first-page":"5786","DOI":"10.1111\/dom.15949","article-title":"In which common chronic conditions can (or cannot) obesity and lifestyle factors explain higher concentrations of C-reactive protein?","volume":"26","author":"Anderson","year":"2024","journal-title":"Diabetes Obes. Metab."},{"issue":"8","key":"10.1016\/j.ijcha.2025.101832_b0040","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1002\/acr.24578","article-title":"Incidence of and risk factors for heart failure in patients with psoriatic disease: a cohort study","volume":"74","author":"Koppikar","year":"2022","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.ijcha.2025.101832_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2025.1538466","article-title":"Systemic inflammation prevalence in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a population-based study using a nationwide primary care database in Spain","volume":"12","author":"Pesce","year":"2025","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101832_b0050","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1161\/01.ATV.0000111245.75752.C6","article-title":"Definition of metabolic syndrome","volume":"24","author":"Grundy","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101832_b0055","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/bjd.16102","article-title":"Safety, efficacy and drug survival of biologics and biosimilars for moderate\u2010to\u2010severe plaque psoriasis","volume":"178","author":"Egeberg","year":"2018","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijcha.2025.101832_b0060","doi-asserted-by":"crossref","DOI":"10.1161\/01.HYP.9.2_Pt_2.II6","article-title":"Reproducibility of echocardiographic left ventricular measurements","volume":"9","author":"Wallerson","year":"1987","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.ijcha.2025.101832_b0065","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.echo.2016.01.011","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the american society of echocardiography and the european association of cardiovascular imaging","volume":"29","author":"Nagueh","year":"2016","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101832_b0070","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.echo.2012.10.008","article-title":"Normal ranges of left ventricular strain: a meta-analysis","volume":"26","author":"Yingchoncharoen","year":"2013","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcha.2025.101832_b0075","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221111131","article-title":"Biomarkers of inflammation and left ventricular remodelling in psoriasis patients treated with infliximab","volume":"36","author":"Midtb\u00f8","year":"2022","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101832_b0080","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction","volume":"62","author":"Paulus","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101832_b0085","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/jdv.15211","article-title":"Role of galectin-3 in subclinical myocardial impairment in psoriasis","volume":"33","author":"Kotwica","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101832_b0090","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1620\/tjem.223.263","article-title":"Association between high-sensitivity c-reactive protein and left ventricular diastolic function assessed by echocardiography in patients with cardiovascular risk factors","volume":"223","author":"Masugata","year":"2011","journal-title":"Tohoku J. Exp. Med."},{"issue":"10","key":"10.1016\/j.ijcha.2025.101832_b0095","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacc.2018.06.050","article-title":"Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction","volume":"72","author":"Tromp","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"19","key":"10.1016\/j.ijcha.2025.101832_b0100","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1161\/01.CIR.100.19.1983","article-title":"Serum from patients with severe heart failure downregulates eNOS and is proapoptotic: role of tumor necrosis Factor-\u03b1","volume":"100","author":"Agnoletti","year":"1999","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.ijcha.2025.101832_b0105","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcha.2025.101832_b0110","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.746494","article-title":"Inflammation in human heart failure: major mediators and therapeutic targets","volume":"12","author":"Reina-Couto","year":"2021","journal-title":"Front. Physiol."},{"issue":"11","key":"10.1016\/j.ijcha.2025.101832_b0115","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jacc.2020.01.014","article-title":"Inflammation in heart Failure","volume":"75","author":"Murphy","year":"2020","journal-title":"JACC"},{"issue":"17","key":"10.1016\/j.ijcha.2025.101832_b0120","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/CIRCULATIONAHA.113.003199","article-title":"Targeting interleukin-1 in heart disease","volume":"128","author":"Van Tassell","year":"2013","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ijcha.2025.101832_b0125","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the D-HART pilot study)","volume":"113","author":"Van Tassell","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcha.2025.101832_b0130","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.cardfail.2021.07.006","article-title":"Mid- to late-life inflammation and risk of cardiac dysfunction, HFpEF, and HFrEF in late-life","volume":"27","author":"Cohen","year":"2021","journal-title":"J. Card. Fail."},{"issue":"9","key":"10.1016\/j.ijcha.2025.101832_b0135","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1097\/HJH.0000000000001013","article-title":"Joint statement of the European association for the study of obesity and the european society of hypertension: obesity and heart failure","volume":"34","author":"Jordan","year":"2016","journal-title":"J. Hypertens."},{"issue":"18","key":"10.1016\/j.ijcha.2025.101832_b0140","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2007.12.048","article-title":"Novel metabolic risk factors for incident heart failure and their relationship with obesity: the MESA (multi-ethnic study of atherosclerosis) study","volume":"51","author":"Bahrami","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101832_b0145","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00031.2016","article-title":"Role of the immune system in hypertension","volume":"97","author":"Rodriguez-Iturbe","year":"2017","journal-title":"Physiol. Rev."},{"issue":"3","key":"10.1016\/j.ijcha.2025.101832_b0150","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.118.11125","article-title":"Myocardial remodeling in hypertension","volume":"72","author":"Gonz\u00e1lez","year":"2018","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.ijcha.2025.101832_b0155","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101832_b0160","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12872-023-03149-3","article-title":"Effect of C-reactive protein on the risk of Heart failure: a mendelian randomization study","volume":"23","author":"Habibi","year":"2023","journal-title":"BMC Cardiovasc. Disord."},{"issue":"46","key":"10.1016\/j.ijcha.2025.101832_b0165","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1093\/eurheartj\/ehy723","article-title":"Has the time finally come to measure hsCRP universally in primary and secondary cardiovascular prevention?","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcha.2025.101832_b0170","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.118.034032","article-title":"Inflammatory and cholesterol risk in the fourier trial","volume":"138","author":"Bohula","year":"2018","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcha.2025.101832_b0175","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1161\/CIRCULATIONAHA.109.874834","article-title":"Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER)","volume":"121","author":"Everett","year":"2010","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcha.2025.101832_b0180","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003989","article-title":"Biomarker profiles in heart failure patients with preserved and reduced ejection fraction","volume":"6","author":"Tromp","year":"2017","journal-title":"J. Am. Heart Assoc."},{"issue":"1","key":"10.1016\/j.ijcha.2025.101832_b0185","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cardfail.2023.10.024","article-title":"HERMES: effects of ziltivekimab versus placebo on morbidity and mortality in patients with heart failure with mildly reduced or preserved ejection fraction and systemic inflammation","volume":"30","author":"Petrie","year":"2024","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.ijcha.2025.101832_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175126","article-title":"Colchicine alleviates inflammation and improves diastolic dysfunction in heart failure rats with preserved ejection fraction","author":"Shen","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijcha.2025.101832_b0195","unstructured":"Zeyad SM. The Role of Colchicine as Anti-Inflammatory Treatment in Patients With HFpEF: A Prospective Study. clinicaltrials.gov; 2025. Accessed July 24, 2025. https:\/\/clinicaltrials.gov\/study\/NCT06837623."},{"key":"10.1016\/j.ijcha.2025.101832_b0200","unstructured":"Biering-S\u00f8rensen T. The COLchicine HEART Failure PRESERVED Trial (COLHEART-PRESERVED). clinicaltrials.gov; 2024. Accessed July 24, 2025. https:\/\/clinicaltrials.gov\/study\/NCT06081049."},{"issue":"10118","key":"10.1016\/j.ijcha.2025.101832_b0205","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"Lancet"},{"issue":"9894","key":"10.1016\/j.ijcha.2025.101832_b0210","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(13)60594-2","article-title":"Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial","volume":"382","author":"McInnes","year":"2013","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101832_b0215","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s40744-022-00434-z","article-title":"Effect of secukinumab on traditional cardiovascular risk factors and inflammatory biomarkers: post hoc analyses of Pooled Data across three Indications","volume":"9","author":"Merola","year":"2022","journal-title":"Rheumatol. Ther."},{"issue":"4","key":"10.1016\/j.ijcha.2025.101832_b0220","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1159\/000520163","article-title":"Evaluation of psoriasis area and severity index thresholds as proxies for systemic inflammation on an individual patient level","volume":"238","author":"Hoffmann","year":"2021","journal-title":"Dermatology"},{"key":"10.1016\/j.ijcha.2025.101832_b0225","doi-asserted-by":"crossref","unstructured":"The Emerging Risk Factors Collaboration. C-Reactive Protein, Fibrinogen, and Cardiovascular Disease Prediction. N Engl J Med. 2012;367(14):1310-1320. doi:10.1056\/NEJMoa1107477.","DOI":"10.1056\/NEJMoa1107477"},{"key":"10.1016\/j.ijcha.2025.101832_b0230","doi-asserted-by":"crossref","unstructured":"2019 ACC\/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. doi:10.1161\/CIR.0000000000000678.","DOI":"10.1161\/CIR.0000000000000678"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101832_b0235","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005521","article-title":"Global longitudinal strain by echocardiography predicts long-term risk of cardiovascular morbidity and mortality in a low-risk general population: the copenhagen City Heart Study","volume":"10","author":"Biering-S\u00f8rensen","year":"2017","journal-title":"Circ. Cardiovasc. Imaging"},{"issue":"3","key":"10.1016\/j.ijcha.2025.101832_b0240","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1093\/clinchem\/47.3.444","article-title":"Variability and classification accuracy of serial high-sensitivity C-reactive protein measurements in healthy adults","volume":"47","author":"Ockene","year":"2001","journal-title":"Clin. Chem."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725002350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906725002350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:43:02Z","timestamp":1764866582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906725002350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":48,"alternative-id":["S2352906725002350"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101832","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High-sensitivity C-reactive protein is associated with altered cardiac structure and function in psoriasis: The PSOCADIA study","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2025.101832","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101832"}}